The present disclosure is related generally to implantable medical devices and more particularly to the fixation of implantable medical devices within body vessels.
Aneurysms occur in blood vessels at sites where, due to age, disease or genetic predisposition of the patient, the strength or resilience of the vessel wall is insufficient to prevent ballooning or stretching of the wall as blood passes through. If the aneurysm is left untreated, the blood vessel wall may expand and rupture, often resulting in death.
To prevent rupturing of an aneurysm, a stent graft may be introduced into a blood vessel percutaneously and then deployed to span the aneurysmal sac. A stent graft includes a graft fabric secured to a cylindrical scaffolding or framework of one or more stents. The stents provide rigidity and structure to hold the graft open in a tubular configuration as well as the outward radial force needed to create a seal between the graft and a healthy portion of the vessel wall. Blood flowing through the vessel can be channeled through the hollow interior of the stent graft to reduce, if not eliminate, the stress on the vessel wall at the location of the aneurysmal sac. Thus, a stent graft may reduce the risk of rupture of the blood vessel wall at the aneurysmal site and allow blood to flow through the vessel without interruption.
Aneurysms occurring in the aorta, the largest artery in the human body, may occur in the chest (thoracic aortic aneurysm) or in the abdomen (abdominal aortic aneurysm). The high velocity of blood within the aorta makes it essential to securely anchor the stent graft to the aortic wall. Migration of the stent graft downstream is prevented, in part, by a frictional interference fit between the vessel wall and an oversized sealing stent at the proximal end of the graft. The integrity of the interference fit may be compromised, however, by changes in the size and morphology of the vessel. Consequently, stent grafts may include anchoring barbs that penetrate the aortic wall to provide additional resistance to migration that is not dependent on the interference fit.
Anchoring barbs experience repetitive loading from hemodynamic forces that are a by-product of the cardiac cycle. Exposure to cyclic loading may lead to premature fracture of the barbs due to fatigue failure.
An improved barb for anchoring an implantable medical device within a body vessel is described herein. The improved barb is designed to have a higher fatigue life than existing barbs.
According to a first aspect of the invention, there is provided a barb comprising a thin-walled body portion for engagement with a structural element of an implantable medical device and a penetrating element extending from the body portion. The body portion has a longitudinal axis. The penetrating element includes a tip portion for anchoring into tissue and a base portion between the tip portion and the body portion. In a deployed configuration of the barb, the base portion curves away from the longitudinal axis at a non-constant radius of curvature and the tip portion is substantially straight.
According to a second aspect of the invention, there is provided a barb comprising a thin-walled body portion for engagement with a structural element of an implantable medical device and a penetrating element extending from the body portion. The body portion has a longitudinal axis. The penetrating element includes a tip portion for anchoring into tissue and a base portion between the tip portion and the body portion. In a deployed configuration of the barb, the base portion curves away from the longitudinal axis at a first curvature and the tip portion curves toward the longitudinal axis at a second curvature which is opposite in sign from the first.
According to a third aspect of the invention, there is provided a barb comprising a thin-walled body portion for engagement with a structural element of an implantable medical device and a penetrating element extending from the body portion. The body portion has a longitudinal axis. The penetrating element includes a tip portion for anchoring into tissue and a base portion between the tip portion and the body portion. In a deployed configuration of the barb, the base portion curves away from the longitudinal axis at a first curvature and the tip portion is substantially straight or curves towards the longitudinal axis at a second curvature which is opposite in sign from the first. The first curvature may have a non constant or variable radius of curvature. The second curvature may have a non constant or variable radius of curvature.
The geometry of the improved barbs distributes the strain over a larger region of the penetrating element compared to the existing barbs. Accordingly, the peak maximum principal strain is decreased. Increasing the length of the base portion of the penetrating element results in a decrease in the maximum principal strain—and thus an improvement in the fatigue life of the barb. The base portion preferably extends over from about 25% to about 50% of the total length of the penetrating element. Advantageously the base portion extends over from about 33% to about 45% of the total length of the penetrating element. A reduction in the curvature of the base portion is also beneficial for reducing the maximum principal strain. Preferably, the peak maximum principal strain experienced by the barb is about 0.5% or less when a longitudinally-directed load of 1.5 N is applied to a midpoint of the penetrating element.
Preferred embodiments of the invention will now be described with reference to the drawings in which:
Referring to
The base portion 130 may extend over as much as about half of the length of the penetrating element 120, so that up to about 50% of the length of the penetrating element 120 curves away from the longitudinal axis 115 at a non-constant radius of curvature. The tip portion 125 extends over the remaining portion of the length of the penetrating element 120; thus, at least about 50% of the length of the penetrating element 120 may be substantially straight, or have a substantially constant slope with respect to the longitudinal axis. Preferably, the base portion 130 extends over at least about one-quarter (25%) of the length of the penetrating element 120, and the tip portion 125 extends over no more than about three-quarters (75%) of the length of the tip portion 125. For example, the base portion 130 may extend over at least about one-third (33%) of the length of the penetrating element 120, and the tip portion 125 may extend over no more than about two-thirds (67%) of the length of the penetrating element 120. In another example, the base portion 130 may extend over at least about 40% of the length of the penetrating element 120, and the tip portion 125 may extend over no more than about 60% of the length of the penetrating element 120. Other proportions of the base portion 130 and tip portion 125 along the length of the penetrating element 120 are also possible, and are determined by the forming process, as discussed in detail below.
As shown in
The base portion 230 may extend over as much as about half of the length of the penetrating element 220, so that up to about 50% of the length of the penetrating element 220 curves away from the longitudinal axis 215. The tip portion 225, which curves toward the longitudinal axis, extends over the remaining portion of the length of the penetrating element 220. Preferably, the base portion 230 extends over at least about one-quarter (25%) of the length of the penetrating element 220, and the tip portion 225 extends over no more than about three-quarters (75%) of the length of the tip portion 225. For example, the base portion 230 may extend over at least about one-third (33%) of the length of the penetrating element 220, and the tip portion 225 may extend over no more than about two-thirds (67%) of the length of the penetrating element 220. In another example, the base portion 230 may extend over at least about 40% of the length of the penetrating element 220, and the tip portion 225 may extend over no more than about 60% of the length of the penetrating element 220. Other proportions of the base portion 230 and tip portion 225 along the length of the penetrating element 220 are also possible, and are determined by the forming process, as discussed in detail below.
As in the previous embodiment, the penetrating element 220 preferably has a decreasing width along its length from the base portion 230 to the tip portion 225. Referring to
The thin-walled body portion 110, 210 of the first or second embodiments of the barb 105, 205 may take the form of a sleeve sized to at least partially surround a structural element of an implantable medical device. The sleeve may completely surround the structural element, as shown in
The thin-walled body portion may be secured to the structural element of the implantable medical device by one or more of an adhesive bond, a thermal bond, a spot weld, a laser weld, a frictional fit, a crimp or another joining mechanism.
The barb may be formed in whole or in part from a shape memory alloy that can “remember” and recover a previous shape. In the case of nickel-titanium shape memory alloys (e.g., Nitinol), the source of the shape recovery is a phase transformation between a lower temperature phase (martensite) and a higher temperature phase (austenite), which may be driven by a change in temperature (shape memory effect) or by the removal of an applied stress (superelastic effect). Strain introduced into the alloy in the martensitic phase to achieve a shape change may be substantially recovered upon completion of a reverse phase transformation to austenite, allowing the alloy to return to the previous shape. Austenite is characteristically the stronger phase, and martensite is the more readily deformable phase which may accommodate recoverable strains of up to about 8-10%.
Slightly nickel-rich Nitinol alloys including, for example, about 51 at. % Ni and about 49 at. % Ti are known to be useful for intraluminal medical devices that are superelastic at body temperature. In particular, alloys including 50.6-50.8 at. % Ni and 49.2-49.4 at. % Ti are considered to be medical grade Nitinol alloys and may be used for the barbs. The nickel-titanium alloy may also include one or more additional alloying elements that may substitute for one or both of the nickel and titanium in the alloy.
It may be particularly advantageous for the barb to be able to “remember” and recover the deployed configuration, where the penetrating element extends away from the longitudinal axis to facilitate tissue penetration, after delivery to an intraluminal treatment site. Accordingly, the barb may undergo a heat-setting treatment during processing that programs a memory of the desired deployed configuration. Thus, the barb (and the medical device to which the barb is affixed) may be delivered into a body vessel in a low-profile delivery configuration and then superelastically deployed to the remembered configuration once in place at the treatment site. A tubular restraining sheath overlying the medical device and the barb(s) may be retracted to deploy the device and barb superelastically.
Set forth herein are proposed methods of forming the barbs into the desired deployed configurations prior to heat-setting.
Referring to
Referring to
Once formed into the desired configuration, the heat-setting treatment mentioned above may be carried out to program the barb with a memory of the configuration. The barb may be constrained by one or more fixtures, mandrels or other suitable constraining members to hold the desired configuration during the heat-setting treatment, which is typically carried out at a temperature in the range of from about 350° C. to about 550° C. The heat setting treatment may be carried out for a time duration of from about 15 minutes to about 60 minutes.
Due to the repetitive loading experienced by barbs in vivo, it is useful to understand how design variations may affect their fatigue performance. The inventors have employed finite element analysis (FEA) using Abaqus/Standard 6.8-1 software to predict the behavior of different Nitinol barb configurations under stress. A 1.5 N load was applied in a longitudinal direction to a midpoint of the penetration element of each barb as modeled by FEA. A material model for Nitinol which is widely accepted in the medical device community was used in the FEA simulations.
From the FEA simulations, it is possible to determine the maximum principal strain experienced by each barb during loading. The strain contours reveal local regions of the barbs that are most highly strained during loading. The peak maximum principal strain is believed to be an indicator of fatigue life; in general, the lower the magnitude of the peak strain, the more fatigue-resistant or durable the barb. The inventors compared the maximum principal strain values for the improved barb configurations described herein to those achieved for a previous barb design disclosed in U.S. Patent Application Publication No. 2005/0240259, which is hereby incorporated by reference in its entirety.
Referring to
Referring to
The FEA data suggest that the geometry of the improved barbs distributes the strain over a larger region of the penetrating element compared to the baseline case. Accordingly, the peak maximum principal strain is decreased. It is believed that by further increasing the length of the base portion of the penetrating element, where the base portion has the curvature of either the first or the second embodiment of the barb, a decrease in the maximum principal strain—and thus an improvement in the fatigue life of the barb—may be achieved. As described above, the base portion preferably extends over from about 25% to about 50% of the total length of the penetrating element. It may be particularly advantageous for the base portion to extend over from about 33% to about 45% of the total length of the penetrating element. A reduction in the curvature of the base portion may also be beneficial for reducing the maximum principal strain. Preferably, based on the above data, the peak maximum principal strain experienced by the barb is about 0.5% or less when a longitudinally-directed load of 1.5 N is applied to a midpoint of the penetrating element.
An improved barb for anchoring an implantable medical device to a body vessel has been described. The improved barb is designed to have a higher fatigue life than existing barbs. Although the present invention has been described in considerable detail with reference to certain embodiments thereof, other embodiments are possible without departing from the present invention. The spirit and scope of the appended claims should not be limited, therefore, to the description of the preferred embodiments contained herein. All embodiments that come within the meaning of the claims, either literally or by equivalence, are intended to be embraced therein. Furthermore, the advantages described above are not necessarily the only advantages of the invention, and it is not necessarily expected that all of the described advantages will be achieved with every embodiment of the invention.
The disclosures in U.S. patent application no. U.S. 61/138,355 from which this patent application claims priority, and in the abstract accompanying this application are incorporated herein by reference.
Filing Document | Filing Date | Country | Kind | 371c Date |
---|---|---|---|---|
PCT/US09/67848 | 12/14/2009 | WO | 00 | 10/7/2011 |
Number | Date | Country | |
---|---|---|---|
61138355 | Dec 2008 | US |